STELARA (USTEKINUMAB) SHOWS POSITIVE RESULTS IN TREATMENT OF SYSTEMIC LUPUS...
STELARA® showed significant reductions in lupus disease activity vs. read more
View ArticleArthritis and Rheumatology publishes positive Phase II data on anifrolumab in...
Gaithersburg, Md, 14 November 2016 - AstraZeneca and its global biologics research and development arm, MedImmune, today announced that Arthritis and Rheumatology has published positive results from...
View Article
More Pages to Explore .....